Miralax



Combined with:

Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 51.9%
Medical Observation 18.8%
Constipation 17.9%
Drug Use For Unknown Indication 1.9%
Colonoscopy 1.7%
Hypertension 1.4%
Bowel Preparation 0.8%
Bowel Movement Irregularity 0.7%
Faeces Hard 0.6%
Diabetes Mellitus 0.6%
Constipation Prophylaxis 0.5%
Pain 0.5%
Irritable Bowel Syndrome 0.4%
Blood Cholesterol Increased 0.4%
Blood Cholesterol 0.4%
Cardiac Disorder 0.4%
Gastrooesophageal Reflux Disease 0.4%
Depression 0.3%
Gastrointestinal Disorder 0.3%
Thyroid Disorder 0.3%
Drug Ineffective 20.6%
Off Label Use 14.0%
Incorrect Drug Administration Duration 11.1%
Overdose 10.7%
Underdose 6.6%
Product Label Confusion 5.0%
Inappropriate Schedule Of Drug Administration 4.1%
Diarrhoea 3.6%
Expired Drug Administered 3.3%
Drug Effect Decreased 3.1%
Flatulence 2.8%
Prescribed Overdose 2.6%
Vomiting 2.3%
Nausea 2.1%
Faeces Discoloured 1.6%
Drug Effect Delayed 1.4%
Wrong Technique In Drug Usage Process 1.4%
Product Taste Abnormal 1.3%
Muscle Spasms 1.2%
Product Quality Issue 1.2%
Secondary
Product Used For Unknown Indication 37.8%
Medical Observation 30.3%
Constipation 15.1%
Pain 2.1%
Hypertension 1.8%
Colonoscopy 1.3%
Diabetes Mellitus 1.2%
Bowel Preparation 1.0%
Blood Cholesterol Increased 0.9%
Gastrooesophageal Reflux Disease 0.9%
Depression 0.9%
Irritable Bowel Syndrome 0.8%
Thyroid Disorder 0.8%
Drug Use For Unknown Indication 0.8%
Faeces Hard 0.8%
Fibromyalgia 0.7%
Bowel Movement Irregularity 0.7%
Obstruction 0.7%
Foetal Exposure During Pregnancy 0.6%
Cardiac Disorder 0.6%
Off Label Use 17.1%
Incorrect Drug Administration Duration 14.6%
Overdose 14.3%
Drug Ineffective 12.0%
Underdose 8.9%
Prescribed Overdose 4.8%
Diarrhoea 4.0%
Inappropriate Schedule Of Drug Administration 4.0%
Vomiting 2.7%
Flatulence 2.6%
Drug Effect Decreased 2.5%
Nausea 1.7%
Expired Drug Administered 1.5%
Fibromyalgia 1.5%
Pain 1.5%
Product Taste Abnormal 1.4%
Wrong Technique In Drug Usage Process 1.3%
Product Label Confusion 1.3%
Incorrect Drug Administration Rate 1.2%
Product Quality Issue 1.2%
Concomitant
Product Used For Unknown Indication 27.7%
Drug Use For Unknown Indication 17.6%
Constipation 9.3%
Pain 8.7%
Gastrooesophageal Reflux Disease 3.6%
Hypertension 3.5%
Multiple Myeloma 3.4%
Nausea 3.3%
Depression 3.1%
Crohn's Disease 2.4%
Anxiety 2.3%
Osteoporosis 2.2%
Asthma 2.1%
Prophylaxis 1.9%
Non-small Cell Lung Cancer 1.8%
Multiple Sclerosis 1.8%
Acute Lymphocytic Leukaemia 1.6%
Insomnia 1.5%
Supplementation Therapy 1.2%
Rheumatoid Arthritis 1.2%
Vomiting 17.2%
Weight Decreased 10.3%
Weight Increased 7.4%
Urinary Tract Infection 6.4%
Death 5.5%
Pain 4.9%
Pneumonia 4.7%
White Blood Cell Count Decreased 4.6%
Nausea 4.4%
Pyrexia 3.9%
Thrombocytopenia 3.8%
Electrocardiogram Qt Prolonged 3.7%
Dyspnoea 3.7%
Pulmonary Embolism 3.1%
Sepsis 2.9%
Tremor 2.9%
Vision Blurred 2.8%
Wheezing 2.6%
Constipation 2.6%
Rash 2.6%
Interacting
Emphysema 17.1%
Constipation 11.4%
Medical Diet 11.4%
Blood Pressure 5.7%
Convulsion 5.7%
Gastrointestinal Disorder 5.7%
Pain 5.7%
Abdominal Discomfort 2.9%
Blood Cholesterol 2.9%
Cardiac Disorder 2.9%
Cough 2.9%
Diarrhoea 2.9%
Flatulence 2.9%
Gastrointestinal Pain 2.9%
Headache 2.9%
Irritable Bowel Syndrome 2.9%
Muscle Spasms 2.9%
Product Used For Unknown Indication 2.9%
Sedative Therapy 2.9%
Trigeminal Nerve Disorder 2.9%
Sedation 33.3%
Constipation 16.7%
Myocardial Infarction 16.7%
Nightmare 16.7%
Urinary Retention 16.7%